SeaStar Medical Holding annual stock-based compensation
2021
2022
2023
2024
2025
SeaStar Medical Holding Stock-Based Compensation Growth & History (ICU)
SeaStar Medical Holding's stock-based compensation was $624,000 for fiscal 2025.
View full SeaStar Medical Holding company overviewSeaStar Medical Holding annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $624,000 | −$263,000 | −29.65% |
| 2024 | 2024-12-31 | $887,000 | −$1.0M | −54.04% |
| 2023 | 2023-12-31 | $1.9M | $619,000 | +47.22% |
| 2022 | 2022-12-31 | $1.3M | $1.3M | +9264.29% |
| 2021 | 2021-12-31 | $14,000 | — | — |
SeaStar Medical Holding quarterly stock-based compensation
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$99,000 | −$196,000 | — |
| Q1 2026 | 2026-03-31 | $91,000 | −$76,000 | −45.51% |
| Q4 2025 | 2025-12-31 | $70,000 | −$142,000 | −66.98% |
| Q3 2025 | 2025-09-30 | $290,000 | $90,000 | +45.00% |
| Q2 2025 | 2025-06-30 | $97,000 | $56,000 | +136.59% |
| Q1 2025 | 2025-03-31 | $167,000 | −$267,000 | −61.52% |
| Q4 2024 | 2024-12-31 | $212,000 | −$174,000 | −45.08% |
| Q3 2024 | 2024-09-30 | $200,000 | −$284,000 | −58.68% |
| Q2 2024 | 2024-06-30 | $41,000 | −$514,000 | −92.61% |
| Q1 2024 | 2024-03-31 | $434,000 | −$71,000 | −14.06% |
| Q4 2023 | 2023-12-31 | $386,000 | −$219,000 | −36.20% |
| Q3 2023 | 2023-09-30 | $484,000 | $127,000 | +35.57% |
| Q2 2023 | 2023-06-30 | $555,000 | $210,000 | +60.87% |
| Q1 2023 | 2023-03-31 | $505,000 | $501,000 | +12525.00% |
| Q4 2022 | 2022-12-31 | $605,000 | — | — |
| Q3 2022 | 2022-09-30 | $357,000 | — | — |
| Q2 2022 | 2022-06-30 | $345,000 | — | — |
| Q1 2022 | 2022-03-31 | $4,000 | — | — |
SeaStar Medical Holding stock-based compensation trends
Between the periods ended 2021-12-31 and 2025-12-31, SeaStar Medical Holding's stock-based compensation increased from $14,000 to $624,000, a change of $610,000. The latest reported quarter, Q2 2026, shows −$99,000.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review SeaStar Medical Holding source filings ↗